BN Business News
أضف شركتك →
تجري حاليًا ترجمة هذا المقال. نعرض مؤقتًا النسخة الأصلية باللغة الإنجليزية.

الطاقة والبيئة · 1‏/12‏/20211 دقائق للقراءة

Advisory Committee on the Medical Uses of Isotopes: Meeting Notice

ترجمة آلية محلية · اللغة الأصلية للمصدر

الملخص

The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on December 15, 2021 to discuss the NRC staff's draft Alpha Tau Alpha Dart TM Manual Brachytherapy Licensing Guidance and the ACMUI Subcommittee on Alpha Dart draft report on the proposed draft licensing guidance; the NRC staff's draft additional licensing considerations memo for CivaTech Oncology Inc.'s CivaDerm TM and the ACMUI Subcommittee ACMUI Subcommittee on Civaderm draft report on the proposed draft memo; the NRC staff's draft revision of Regulatory Guide 8.39, "Release of Patients Administered Radioactive Material and the ACMUI Subcommittee on Regulatory Guide 8.39, "Release of Patients Administered Radioactive Material" draft report on the proposed draft revision of the regulatory guide. The meeting agenda is subject to change. The current agenda and any updates will be available on the ACMUI's Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/ 2021.html or by emailing Mr. Don Lowman at the contact information below.

اللغة الأصلية للمصدر: Federal Register — Nuclear Regulatory Commissionافتح البيان الأصلي →

استكشف الموضوعات

تحليلات الأعمال →